BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34333303)

  • 1. Augment the efficacy of eradicating metastatic lesions and tumor proliferation in breast cancer by honokiol-loaded pH-sensitive targeted lipid nanoparticles.
    Zhang H; Li J; Yuan R; Li Y; Zhang Y; Hu X; Qu J; Chen Y; Wang Z; Xia M; Wang D
    Colloids Surf B Biointerfaces; 2021 Nov; 207():112008. PubMed ID: 34333303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface modification of pH-sensitive honokiol nanoparticles based on dopamine coating for targeted therapy of breast cancer.
    Yu R; Zou Y; Liu B; Guo Y; Wang X; Han M
    Colloids Surf B Biointerfaces; 2019 May; 177():1-10. PubMed ID: 30690424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis.
    Shi J; Ren Y; Ma J; Luo X; Li J; Wu Y; Gu H; Fu C; Cao Z; Zhang J
    J Nanobiotechnology; 2021 Jun; 19(1):188. PubMed ID: 34162396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
    Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
    Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of honokiol by zein/hyaluronic acid core-shell nanoparticles to suppress breast cancer growth and metastasis.
    Zhang Q; Wang J; Liu D; Zhu W; Guan S; Fan L; Cai D
    Carbohydr Polym; 2020 Jul; 240():116325. PubMed ID: 32475585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimuli-responsive polymeric prodrug-based nanomedicine delivering nifuroxazide and doxorubicin against primary breast cancer and pulmonary metastasis.
    Luo L; Xu F; Peng H; Luo Y; Tian X; Battaglia G; Zhang H; Gong Q; Gu Z; Luo K
    J Control Release; 2020 Feb; 318():124-135. PubMed ID: 31838206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-Responsive Wormlike Micelles with Sequential Metastasis Targeting Inhibit Lung Metastasis of Breast Cancer.
    He X; Yu H; Bao X; Cao H; Yin Q; Zhang Z; Li Y
    Adv Healthc Mater; 2016 Feb; 5(4):439-48. PubMed ID: 26711864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model.
    Nordin N; Yeap SK; Rahman HS; Zamberi NR; Mohamad NE; Abu N; Masarudin MJ; Abdullah R; Alitheen NB
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32526880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells.
    da Rocha MCO; da Silva PB; Radicchi MA; Andrade BYG; de Oliveira JV; Venus T; Merker C; Estrela-Lopis I; Longo JPF; Báo SN
    J Nanobiotechnology; 2020 Mar; 18(1):43. PubMed ID: 32164731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.
    Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y
    Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-Sensitive Nanoparticles Codelivering Docetaxel and Dihydroartemisinin Effectively Treat Breast Cancer by Enhancing Reactive Oxidative Species-Mediated Mitochondrial Apoptosis.
    Tao J; Diao L; Chen F; Shen A; Wang S; Jin H; Cai D; Hu Y
    Mol Pharm; 2021 Jan; 18(1):74-86. PubMed ID: 33084332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pH-sensitive nanotherapeutic system based on a marine sulfated polysaccharide for the treatment of metastatic breast cancer through combining chemotherapy and COX-2 inhibition.
    Zhang T; Liu H; Li Y; Li C; Wan G; Chen B; Li C; Wang Y
    Acta Biomater; 2019 Nov; 99():412-425. PubMed ID: 31494294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
    Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
    Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy.
    Gong C; Yu X; You B; Wu Y; Wang R; Han L; Wang Y; Gao S; Yuan Y
    J Nanobiotechnology; 2020 Jun; 18(1):92. PubMed ID: 32546174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis.
    Liu Y; Xie X; Hou X; Shen J; Shi J; Chen H; He Y; Wang Z; Feng N
    J Nanobiotechnology; 2020 May; 18(1):83. PubMed ID: 32473632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.
    Gao F; Zhang J; Fu C; Xie X; Peng F; You J; Tang H; Wang Z; Li P; Chen J
    Int J Nanomedicine; 2017; 12():4147-4162. PubMed ID: 28615942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
    Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
    Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
    Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
    Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-Sensitive Nano-Complexes Overcome Drug Resistance and Inhibit Metastasis of Breast Cancer by Silencing Akt Expression.
    Yin J; Lang T; Cun D; Zheng Z; Huang Y; Yin Q; Yu H; Li Y
    Theranostics; 2017; 7(17):4204-4216. PubMed ID: 29158820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alendronate/folic acid-decorated polymeric nanoparticles for hierarchically targetable chemotherapy against bone metastatic breast cancer.
    Chen SH; Liu TI; Chuang CL; Chen HH; Chiang WH; Chiu HC
    J Mater Chem B; 2020 May; 8(17):3789-3800. PubMed ID: 32150202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.